Preliminary results of the AIM trial of ibrutinib and venetoclax in mantle cell lymphoma
Results of trial of venetoclax with bendamustine/rituximab or bendamustine/obinutuzumab in CLL
iwCLL – International Workshop on Chronic Lymphocytic Leukemia
Federico Caligaris-Cappio et al.
The importance of considering a CLL patient's tumor lysis risk status
The benefits of lenalidomide and dexamethasone for multiple myeloma